There are no laws in place preventing CBIS from bringing a Cannabis based med to the FDA. If there were, GW Pharma would not be in phase 3 of clinical trials with the FDA. That is not what is holding CBIS back. What is holding them back is lack of research on their part and NO MONEY.
All posts are only my opinion. Please do your own research before investing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.